Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
0.4613
Dollar change
-0.0067
Percentage change
-1.43
%
Index- P/E- EPS (ttm)-1.57 Insider Own38.54% Shs Outstand10.40M Perf Week2.06%
Market Cap5.65M Forward P/E- EPS next Y- Insider Trans0.22% Shs Float7.53M Perf Month-27.90%
Income-17.89M PEG- EPS next Q-0.42 Inst Own12.46% Short Float1.84% Perf Quarter-80.12%
Sales5.16M P/S1.10 EPS this Y- Inst Trans-11.55% Short Ratio0.35 Perf Half Y-85.17%
Book/sh-0.56 P/B- EPS next Y- ROA-231.04% Short Interest0.14M Perf Year-85.02%
Cash/sh0.15 P/C3.05 EPS next 5Y- ROE- 52W Range0.33 - 5.39 Perf YTD-87.29%
Dividend Est.- P/FCF- EPS past 5Y64.46% ROI- 52W High-91.44% Beta0.48
Dividend TTM- Quick Ratio0.25 Sales past 5Y49.19% Gross Margin92.70% 52W Low38.16% ATR (14)0.07
Dividend Ex-DateDec 19, 2022 Current Ratio0.25 EPS Y/Y TTM92.47% Oper. Margin-303.10% RSI (14)38.83 Volatility9.72% 13.08%
Employees11 Debt/Eq- Sales Y/Y TTM- Profit Margin-346.56% Recom1.00 Target Price10.75
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-15.95% Payout- Rel Volume0.04 Prev Close0.47
Sales Surprise- EPS Surprise- Sales Q/Q-100.00% EarningsMay 15 AMC Avg Volume397.02K Price0.46
SMA20-13.94% SMA50-13.38% SMA200-79.84% Trades Volume17,171 Change-1.43%
May-15-24 09:54PM
04:15PM
04:01PM
Apr-08-24 04:01PM
Mar-21-24 10:54PM
04:02PM Loading…
04:02PM
Mar-12-24 08:00AM
Feb-29-24 09:36AM
08:30AM
Feb-22-24 08:30AM
Feb-14-24 08:30AM
Feb-07-24 08:30AM
Jan-17-24 08:30AM
Jan-04-24 08:30AM
Dec-15-23 08:35AM
08:30AM Loading…
Dec-13-23 08:30AM
Dec-12-23 01:02PM
09:24AM
Nov-28-23 08:30AM
Nov-09-23 08:30AM
Nov-06-23 08:30AM
Nov-03-23 04:07PM
04:01PM
04:00PM
Oct-17-23 08:30AM
Oct-12-23 10:19AM
07:20AM
Oct-09-23 12:10PM
Oct-05-23 04:09PM
Oct-04-23 08:30AM
08:00AM Loading…
08:00AM
Oct-03-23 08:30AM
Sep-28-23 09:30AM
Sep-25-23 09:30AM
Sep-18-23 09:30AM
Sep-16-23 09:00PM
Aug-31-23 09:30AM
Aug-16-23 06:44AM
Aug-11-23 04:07PM
04:01PM
Aug-04-23 06:23AM
Aug-03-23 08:03AM
Jul-26-23 01:30PM
Jun-29-23 06:30AM
Jun-28-23 06:30AM
Jun-20-23 05:50AM
May-24-23 06:30AM
May-23-23 06:30AM
May-11-23 05:39PM
05:20PM
Apr-24-23 04:01PM
Apr-20-23 08:38AM
Apr-17-23 06:30AM
Apr-12-23 06:30AM
Apr-03-23 06:30AM
Mar-31-23 04:01PM
Mar-22-23 06:30AM
Mar-08-23 06:30AM
Mar-06-23 06:30AM
Mar-01-23 06:30AM
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bartoszek Raymond J.DirectorDec 06 '23Buy4.502501,12517,206Dec 06 06:21 PM
Bartoszek Raymond J.DirectorDec 05 '23Buy4.501,0004,50016,956Dec 06 06:21 PM
Bartoszek Raymond J.DirectorDec 04 '23Buy4.331,0004,32515,956Dec 06 06:21 PM
Iadonato ShawnChief Executive OfficerNov 29 '23Buy3.514,10014,403675,230Nov 30 05:21 PM
PHILIPS CRAIG W.PresidentNov 28 '23Buy3.273,0009,81260,811Nov 30 05:27 PM
Iadonato ShawnChief Executive OfficerNov 28 '23Buy3.339002,995671,130Nov 30 05:21 PM
Foote Marion RDirectorOct 11 '23Option Exercise0.144,443622143,204Oct 12 04:25 PM
PHILIPS CRAIG W.PresidentSep 21 '23Buy2.402,9006,97057,811Sep 21 04:58 PM
Iadonato ShawnChief Executive OfficerSep 20 '23Buy2.5010,00025,042670,230Sep 21 04:57 PM
Kenny PaulineGeneral Counsel & SecretarySep 20 '23Buy2.581,5003,87018,448Sep 21 04:57 PM
PHILIPS CRAIG W.PresidentSep 20 '23Buy2.546001,52554,911Sep 21 04:58 PM
Bartoszek Raymond J.DirectorSep 19 '23Buy2.372,0004,74514,956Sep 21 04:56 PM
Baker KeithChief Financial OfficerSep 18 '23Buy2.135,00010,67216,880Sep 19 05:03 PM
Bartoszek Raymond J.DirectorSep 18 '23Buy2.082,5005,20012,956Sep 19 05:02 PM
Bartoszek Raymond J.DirectorSep 15 '23Buy2.185001,09010,456Sep 19 05:02 PM
Guillaudeux ThierryChief Scientific OfficerSep 14 '23Buy2.0010,00020,00021,696Sep 15 06:49 PM
Baker KeithChief Financial OfficerJun 16 '23Buy2.925,00014,60011,880Jun 16 04:28 PM
Bartoszek Raymond J.DirectorJun 14 '23Option Exercise0.1460,0188,403844,478Jun 16 04:29 PM
PHILIPS CRAIG W.PresidentJun 14 '23Option Exercise0.141,38219334,654Jun 16 04:31 PM
Iadonato ShawnChief Executive OfficerJun 14 '23Option Exercise0.141,382193667,669Jun 16 04:29 PM